Today: 7 February 2026
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Energizer Holdings (ENR) Stock Plunges Over 20% After Q4 2025 Earnings Miss and Cautious 2026 Outlook

Energizer Holdings (ENR) Stock Plunges Over 20% After Q4 2025 Earnings Miss and Cautious 2026 Outlook

Energizer Holdings, Inc. (NYSE: ENR) shares are under heavy pressure today after the battery and auto-care company reported fiscal fourth-quarter 2025 results that missed Wall Street profit expectations and issued a cautious earnings outlook for fiscal 2026, citing tariff headwinds and softer consumer demand. PR Newswire+2Zacks+2 Around mid-morning, ENR was trading near $18.20, down roughly 23–24% on the day, wiping out hundreds of millions of dollars in market value in a single session. ChartMill Key Takeaways for ENR Investors Today Q4 2025: Sales Up, Profits Down as Organic Demand Softens Energizer’s fiscal fourth quarter, covering the period ended September 30,
18 November 2025
··
Amer Sports (AS) Jumps After Q3 2025 Earnings Beat and Raised Outlook as Salomon & Arc’teryx Power 30% Sales Surge

Amer Sports (AS) Jumps After Q3 2025 Earnings Beat and Raised Outlook as Salomon & Arc’teryx Power 30% Sales Surge

Amer Sports, the Finnish parent of premium outdoor and sports brands like Arc’teryx, Salomon and Wilson, delivered a blockbuster third quarter on Tuesday, beating Wall Street expectations, raising full‑year 2025 guidance for the second time this year and sending its stock sharply higher. investors.amersports.com+2amersports.com+2 Key takeaways from Amer Sports’ Q3 2025 report Q3 2025: 30% revenue growth and a clean beat Amer Sports’ official release described Q3 2025 as a period of “strong momentum” as the company’s portfolio of premium technical brands gained share in sports and outdoor markets globally. investors.amersports.com+2Stock Titan+2 For the quarter ended 30 September 2025, Amer
18 November 2025
·
Clearmind Medicine (CMND) Delivers Positive AUD Trial Data Amid New Depression Patent – Nov. 18, 2025

Clearmind Medicine (CMND) Delivers Positive AUD Trial Data Amid New Depression Patent – Nov. 18, 2025

Clearmind Medicine Inc. (NASDAQ: CMND, FSE: CWY0) is back in the spotlight today after releasing positive top-line results from the first cohort of its FDA‑approved Phase I/IIa clinical trial for CMND‑100 in alcohol use disorder (AUD). The update lands just one day after the company highlighted a new Israeli patent filing for a non‑hallucinogenic depression therapy, and as a fresh equity offering is expected to close around today’s date. GlobeNewswire+2GlobeNewswire+2 The cluster of announcements is drawing intense trading interest. As of mid‑afternoon on November 18, CMND shares were changing hands around $0.27, after touching an intraday high near $0.39, on
18 November 2025
Lowe’s (LOW) Stock Slips as Wall Street Braces for Q3 2025 Earnings, Dividend and Big Fund Moves – November 18, 2025

Lowe’s (LOW) Stock Slips as Wall Street Braces for Q3 2025 Earnings, Dividend and Big Fund Moves – November 18, 2025

Lowe’s Companies, Inc. (NYSE: LOW) heads into a pivotal week with its third‑quarter 2025 earnings report due on Wednesday, November 19, against a backdrop of fresh Home Depot results, a newly declared dividend, and notable moves by major institutional investors. With the home improvement sector still digesting higher rates, tariffs and a slower housing market, Lowe’s is under intense scrutiny from Wall Street, options traders and retail investors alike. LOW stock today: drifting lower ahead of earnings Lowe’s shares traded lower on Tuesday as investors reacted to Home Depot’s mixed Q3 results and positioned ahead of Lowe’s own earnings call.
18 November 2025
··
Gorilla Technology (GRRR) Soars on Record Q3 Earnings, $1.4B AI Data Centre Deal and Bullish 2026 Outlook

Gorilla Technology (GRRR) Soars on Record Q3 Earnings, $1.4B AI Data Centre Deal and Bullish 2026 Outlook

Gorilla Technology Group Inc. (NASDAQ: GRRR) is back on the radar as its share price jumps on November 18, 2025, after the AI infrastructure company reported record third‑quarter results, a massive AI data centre mandate, and ambitious guidance for 2026. Record Q3 2025: Strongest Quarter in Company History Gorilla Technology Group Inc., a London‑headquartered AI and security infrastructure company, has reported the strongest quarter in its history for Q3 2025, with numbers that are reshaping how investors view the small‑cap AI name. In a press release dated November 17, later filed as a Form 6‑K, the company reported: Nasdaq+2investors.gorilla-technology.com+2 Adjusted
18 November 2025
···
NICE Ltd (NICE) Stock Hits Lowest Level Since 2019 as Wall Street Slashes Price Targets After AI-First Pivot

NICE Ltd (NICE) Stock Hits Lowest Level Since 2019 as Wall Street Slashes Price Targets After AI-First Pivot

Shares slump despite strong Q3 results as investors digest heavier AI spending, lower 2026 margins and fresh analyst downgrades — while new CX partnerships and leadership moves underscore NICE’s long‑term AI ambitions. Shares of NICE Ltd. (NASDAQ: NICE; TASE: NICE) tumbled to their lowest level since 2019 on Tuesday after the Israeli software company used its Capital Markets Day to outline an aggressive AI‑first investment plan that will compress margins in 2026, even as it highlights accelerating cloud and AI growth and announces a new strategic partnership with IGT Solutions. Yahoo Finance+3NiCE+3ctech+3 The stock’s sharp slide prompted a wave of
18 November 2025
····
Onfolio Holdings (ONFO) Lands Up to $300 Million for Crypto Treasury as Q3 Loss Widens

Onfolio Holdings (ONFO) Lands Up to $300 Million for Crypto Treasury as Q3 Loss Widens

Onfolio’s $300 Million Financing: What Was Announced Today This morning, Onfolio Holdings announced it has secured up to $300 million in financing through a convertible note facility with a U.S.-based institutional investor. GlobeNewswire+1 According to the company: Onfolio describes the facility as “transformative,” arguing it will: How the money will be used For the first $6 million: For future tranches, the company plans to allocate: CEO Dom Wells framed the move as part of a “modern public holding company model” that combines: While the press release confirms the financing is via convertible notes, key terms such as conversion price, interest
18 November 2025
·
Freeport-McMoRan (FCX) Rallies as Grasberg Restart Plan Offsets Class-Action Fallout – 18 November 2025

Freeport-McMoRan (FCX) Rallies as Grasberg Restart Plan Offsets Class-Action Fallout – 18 November 2025

Freeport-McMoRan Inc. (NYSE: FCX) is firmly back in the spotlight today. Shares of the copper and gold producer are trading higher after the company laid out a detailed restart plan for its Grasberg operations in Indonesia, even as fresh securities class‑action announcements keep legal risks front and center. As of early U.S. afternoon trading on Tuesday, FCX was changing hands around $40–41, up roughly 4–6% on the day, with pre‑market trading earlier showing gains of about 5%.TradingView+1 The move follows Freeport’s official update on restart plans for the Grasberg minerals district, a scheduled conference call with investors, new guidance on
18 November 2025
·
Arvinas (ARVN) Soars 14% as Investors Cheer Pipeline Reset and Jefferies Update

Arvinas (ARVN) Soars 14% as Investors Cheer Pipeline Reset and Jefferies Update

Arvinas (NASDAQ: ARVN) jumped in double digits on November 18, 2025 amid a focused pipeline reset, FDA momentum for vepdegestrant and attention at the Jefferies London Healthcare Conference. ARVN stock pops on November 18, 2025 Arvinas shares are in rally mode this Tuesday. By mid‑afternoon U.S. trading, ARVN is up more than 14% on the day, with intraday prices hovering around the low‑$13 level and turnover far above normal. Quiver Quantitative+1 Pre‑market data set the tone: ChartMill flagged Arvinas as one of the most active names before the bell, with premarket quotes around $13.60, up more than 23% from the
18 November 2025
·
Intuit (INTU) Stock Rises on $100M+ OpenAI Deal to Bring TurboTax and QuickBooks Into ChatGPT

Intuit (INTU) Stock Rises on $100M+ OpenAI Deal to Bring TurboTax and QuickBooks Into ChatGPT

Intuit Inc. (NASDAQ: INTU) is back in the AI spotlight today after unveiling a multi‑year partnership with OpenAI that will see flagship products like TurboTax, QuickBooks, Credit Karma and Mailchimp embedded directly inside ChatGPT. The company has also signed a contract worth more than $100 million to deepen its use of OpenAI’s models across its own AI platform, GenOS. Intuit Inc.+1 The market likes what it sees. As of this afternoon, Intuit shares are trading around $652.98, up roughly 1% on the day, after earlier spiking as investors digested the news and fresh bullish commentary from Wall Street. Investing.com Key
18 November 2025
··
Temu Owner PDD Holdings Beats Profit Forecasts but Warns of Slower Growth as Stock Slides on Q3 2025 Results

Temu Owner PDD Holdings Beats Profit Forecasts but Warns of Slower Growth as Stock Slides on Q3 2025 Results

Chinese e-commerce group PDD Holdings Inc. (NASDAQ: PDD), the parent of bargain-shopping apps Pinduoduo and Temu, reported third-quarter 2025 results on Tuesday (18 November 2025) that showed solid profit growth and robust cash generation — but a clear slowdown in revenue growth. That combination sent the stock lower in U.S. trading as investors weighed strong margins against a tougher competitive and regulatory backdrop. GlobeNewswire+2Reuters+2 Key Q3 2025 numbers at a glance For the quarter ended 30 September 2025, PDD reported: GlobeNewswire+1 On most profit metrics, PDD comfortably beat Wall Street forecasts. Zacks data show adjusted earnings of US$2.96 per ADS,
18 November 2025
···
Can-Fite BioPharma (CANF) Soars on 9-Year Liver Cancer Survival Breakthrough with Namodenoson – November 18, 2025

Can-Fite BioPharma (CANF) Soars on 9-Year Liver Cancer Survival Breakthrough with Namodenoson – November 18, 2025

Small-cap Israeli biotech rallies after reporting a decade-long cancer‑free outcome in advanced hepatocellular carcinoma and launching enrollment in a pivotal Phase III trial. Shares of Can-Fite BioPharma Ltd. (NYSE American: CANF, TASE: CANF) jumped on Tuesday after the company reported a striking 9‑year overall survival with a complete response in an advanced liver cancer patient treated with its investigational drug Namodenoson, and confirmed that a pivotal Phase III trial in hepatocellular carcinoma (HCC) is now enrolling patients in multiple regions. GlobeNewswire+1 According to real‑time market data, Can-Fite’s American Depositary Receipts (ADRs) traded around $0.47 on November 18, up more than
18 November 2025
··
Baidu (BIDU) Q3 2025 Earnings: Revenue Falls 7% as AI Cloud and Robotaxis Power a Big EPS Beat

Baidu (BIDU) Q3 2025 Earnings: Revenue Falls 7% as AI Cloud and Robotaxis Power a Big EPS Beat

Baidu, Inc. (NASDAQ: BIDU), China’s dominant search engine and a fast‑moving AI heavyweight, reported third‑quarter 2025 results that highlight a company in the middle of a painful but deliberate transformation. Revenue declined as legacy online ads slumped, but Baidu still delivered a strong earnings beat on the back of its AI cloud, autonomous‑driving platform Apollo Go, and a rapidly expanding portfolio of AI‑powered services. PR Newswire Key Takeaways for Baidu (BIDU) Today Earnings Overview: A Tale of Two P&Ls On the surface, Baidu’s Q3 2025 numbers look grim: a mid‑single‑digit revenue decline and a multibillion‑yuan GAAP loss. But the story
18 November 2025
·
Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Published: November 18, 2025 Medtronic plc (NYSE: MDT) is back in the spotlight today after reporting stronger‑than‑expected results for the second quarter of fiscal 2026 and raising its full‑year outlook. The medical technology giant delivered solid revenue and earnings growth, highlighted powerful momentum in its cardiac ablation franchise, and signaled confidence in accelerating growth in the second half of the year. Medtronic News+1 Shares of Medtronic jumped intraday to around $100–101, up roughly 4–5% after the announcement, as investors reacted to a classic “beat‑and‑raise” quarter. ChartMill Q2 FY26 by the numbers: solid beat on revenue and EPS For the quarter
18 November 2025
···
VOO Today: Vanguard S&P 500 ETF slips as Wall Street braces for Nvidia earnings and a heavy data slate — Nov. 18, 2025

VOO Today: Vanguard S&P 500 ETF slips as Wall Street braces for Nvidia earnings and a heavy data slate — Nov. 18, 2025

The S&P 500 tracker softens after Monday’s tech-led selloff; fund flows stay robust as traders focus on Nvidia’s Q3 FY26 results and mid‑week macro releases. What’s moving VOO today The Vanguard S&P 500 ETF (VOO) is easing in Tuesday trade after a weak Monday for large‑cap tech dragged the broad market lower. AP’s market wrap shows the S&P 500 at 6,672.41 (-0.9%) to start the week, reflecting investors’ caution into a pivotal round of AI and macro catalysts. AP News Pre‑market on Tuesday, TipRanks flagged VOO down about 0.5% and highlighted the market’s fixation on Nvidia’s Q3 FY26 report on
18 November 2025
··
VTI vs. SCHB on November 18, 2025: What’s Moving Vanguard’s Total‑Market ETF Today—and Which “Total Stock” Fund Has the Edge?

VTI vs. SCHB on November 18, 2025: What’s Moving Vanguard’s Total‑Market ETF Today—and Which “Total Stock” Fund Has the Edge?

1) What’s moving VTI today (Nov 18, 2025) Wall Street’s tone turned defensive into Tuesday as tech‑valuation concerns, a deepening crypto drawdown, and anticipation of Nvidia’s quarterly results stoked the highest VIX in about a month. U.S. benchmarks finished almost 1% lower on Monday and futures stayed soft before the open. That macro mix is the dominant driver for broad beta ETFs like VTI today. Reuters Within the fund, mega‑cap tech remains the swing factor: Nvidia, Apple, and Microsoft are VTI’s top weights, so any pre‑earnings repositioning or AI‑bubble worries tend to ripple through the ETF. TipRanks’ daily snapshot also
18 November 2025
·
Emirates turns the screws on Boeing with $38B 777X order as it snubs Airbus A350‑1000 over engine concerns — Dubai Airshow 2025

Emirates turns the screws on Boeing with $38B 777X order as it snubs Airbus A350‑1000 over engine concerns — Dubai Airshow 2025

Emirates used day two of the Dubai Airshow to keep pressure on Boeing to execute a blockbuster $38 billion order for 65 additional 777‑9s, while dashing hopes of a fresh Airbus A350‑1000 deal until Rolls‑Royce engine upgrades arrive later this decade. The moves cement Emirates’ bet on very‑large twinjets and intensify the wide‑body dogfight between Boeing and Airbus. Emirates+2Boeing Investors+2 Emirates doubles down on very‑large twins A day after unveiling the deal, Emirates detailed how the additional 65 777‑9s (powered by GE9X engines) align with Dubai’s long‑term hub growth. The airline’s orderbook with Boeing now spans 315 wide‑bodies (270 777X, 10
18 November 2025
·
Stock Market Today (Nov. 18, 2025): Nasdaq slides as AI trade stumbles; Tesla, Palantir, SMCI pace tech losses ahead of Nvidia earnings; Disney ends YouTube TV blackout

Stock Market Today (Nov. 18, 2025): Nasdaq slides as AI trade stumbles; Tesla, Palantir, SMCI pace tech losses ahead of Nvidia earnings; Disney ends YouTube TV blackout

Market snapshot — mid‑day Tuesday, Nov. 18 AI trade under pressure: Why Nvidia’s print looms so large Tech led the sell‑off again as investors questioned whether multi‑quarter AI capex can keep delivering near‑term returns. With Nvidia set to report Wednesday, options markets are braced for a ~7% swing that could ripple across index‑heavy tech and AI hardware/software cohorts. A move of that size would rank among the largest post‑earnings value changes ever for the company. Reuters Wall Street commentary also leaned cautious on valuations after the fall’s powerful rally. AP noted that AI bubble fears have risen—45% of global fund
18 November 2025
··
Microsoft (MSFT) and Amazon (AMZN) Downgraded to Neutral by Rothschild & Co Redburn on AI Capex Concerns — Stocks Slip on Nov. 18, 2025

Microsoft (MSFT) and Amazon (AMZN) Downgraded to Neutral by Rothschild & Co Redburn on AI Capex Concerns — Stocks Slip on Nov. 18, 2025

Rothschild & Co Redburn broke with the prevailing Wall Street optimism on Tuesday, cutting ratings on Microsoft and Amazon to Neutral from Buy. Analyst Alexander (Alex) Haissl also lowered Microsoft’s 12‑month price target to $500 (from $560) and kept Amazon’s target at $250, calling for a more cautious stance on the hyperscaler complex. The call marks Haissl’s first downgrade of the two since initiating coverage in 2022. Bloomberg+1 Market reaction (intraday): As of 15:45 UTC, MSFT traded near $490.55 (≈ ‑3.3%) and AMZN around $224.35 (≈ ‑3.7%), underperforming the broader market as investors digested the sector‑wide implications. Why Redburn turned
18 November 2025
··
Stock Market Today, 18 November 2025: Dow Extends Slide as AI Bubble Fears Grow and Home Depot Earnings Rattle Wall Street

Stock Market Today, 18 November 2025: Dow Extends Slide as AI Bubble Fears Grow and Home Depot Earnings Rattle Wall Street

U.S. stocks spent Tuesday under pressure again as worries about an overheated artificial‑intelligence trade, a disappointing update from Home Depot, and a drumbeat of mixed economic signals kept investors firmly in “risk‑off” mode. By late morning in New York, the Dow Jones Industrial Average was down close to 1%, while the S&P 500 slipped around 0.5% and the Nasdaq 100 nearly 0.9%, with all three benchmarks hovering near one‑month lows and extending Monday’s roughly 1% drop. Barchart.com+1 At the center of the selling: renewed AI bubble fears ahead of Nvidia’s blockbuster earnings on Wednesday, and fresh signs that U.S. consumers
18 November 2025
·
1 … 19 20 21 22 23 … 140

Stock Market Today

Netflix stock price ends higher as DOJ widens review of Warner deal — what to watch next week

Netflix stock price ends higher as DOJ widens review of Warner deal — what to watch next week

7 February 2026
Netflix shares rose 1.6% to $82.20 Friday as the Justice Department expanded its antitrust review of the company’s planned $82.7 billion Warner Bros Discovery acquisition. A Wall Street Journal report said investigators are probing possible anti-competitive tactics. Director Reed Hastings reported a transfer of 241,944 shares via a family trust, according to an SEC filing.
Go toTop